TA162: Lung cancer (non-small-cell) - erlotinib: guidance (MS Word format)
|
TA162: Lung cancer (non-small-cell) - erlotinib: guidance (MS Word format)
26 November 2008 (597.5 Kb 2 mins 54 sec) |
